Ysebaert L, Protin C, Oberic L, Beziat G, et al. Ibrutinib pharmacokinetics in B-lymphoproliferative disorders discloses exposure-related incidence of hypertension. J Hypertens 2024 Dec 4. doi: 10.1097/HJH.0000000000003937.
PMID: 39835452